Reference health
Adiponectin and Hypertension
1 of 81 checkable references need attention · checked 2026-07-23
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1172/JCI200421625
The 80 checked references that resolve
resolves10.1126/science.7678183
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
resolves10.1038/nm0796-800
Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty
resolves10.1161/01.CIR.102.11.1296
Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent Pathway
resolves10.1038/nature01705
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
resolves10.1006/bbrc.1996.0587
cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)
resolves10.1074/jbc.270.45.26746
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
resolves10.1006/bbrc.1999.0255
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
resolves10.1016/S0895-7061(02)03197-7
Decreased plasma adiponectin concentration in patients with essential hypertension
resolves10.1161/01.HYP.0000129281.03801.4b
Hypoadiponectinemia Is an Independent Risk Factor for Hypertension
resolves10.2337/diabetes.50.5.1126
Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus Monkeys
resolves10.1161/01.HYP.0000222368.43759.a1
Adiponectin Replenishment Ameliorates Obesity-Related Hypertension
resolves10.1161/01.CIR.0000042707.50032.19
Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice
resolves10.1038/nm1295
Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms
resolves10.1074/jbc.M310389200
Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells
resolves10.1074/jbc.M402558200
Adiponectin Stimulates Angiogenesis in Response to Tissue Ischemia through Stimulation of AMP-activated Protein Kinase Signaling
resolves10.1074/jbc.M307878200
Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells
resolves10.1161/01.RES.0000119921.86460.37
Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin
resolves10.1128/MCB.00126-09
Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism
resolves10.1074/jbc.M109.088708
Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype
resolves10.1161/01.CIR.0000018622.84402.FF
Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell
resolves10.2337/diacare.25.6.971
Young Men With High-Normal Blood Pressure Have Lower Serum Adiponectin, Smaller LDL Size, and Higher Elevated Heart Rate Than Those With Optimal Blood Pressure
resolves10.1291/hypres.26.705
Role of Adiponectin in Insulin-Resistant Hypertension and Atherosclerosis
resolves10.1111/j.1365-2265.2004.02063.x
Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans
resolves10.1161/HYPERTENSIONAHA.107.086835
Hypoadiponectinemia as a Predictor for the Development of Hypertension
resolves10.1016/j.jacc.2003.10.049
Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease
resolves10.1016/S0006-291X(03)00940-9
Disturbed secretion of mutant adiponectin associated with the metabolic syndrome
resolves10.1210/en.2009-0806
Adiponectin Deficiency, Diastolic Dysfunction, and Diastolic Heart Failure
resolves10.1161/01.HYP.0000083488.67550.B8
Association of Hypoadiponectinemia With Impaired Vasoreactivity
resolves10.1210/jc.2002-021883
Hypoadiponectinemia Is Closely Linked to Endothelial Dysfunction in Man
resolves10.1210/jc.2003-031012
Hypoadiponectinemia Is Associated with Impaired Endothelium-Dependent Vasodilation
resolves10.1002/ajmg.1229
Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis
resolves10.1161/CIRCULATIONAHA.107.725044
Adiponectin Prevents Cerebral Ischemic Injury Through Endothelial Nitric Oxide Synthase–Dependent Mechanisms
resolves10.1074/jbc.M805301200
Caloric Restriction Stimulates Revascularization in Response to Ischemia via Adiponectin-mediated Activation of Endothelial Nitric-oxide Synthase
resolves10.1172/JCI29623
Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo
resolves10.2337/db06-1580
Adiponectin-Induced Endothelial Nitric Oxide Synthase Activation and Nitric Oxide Production Are Mediated by APPL1 in Endothelial Cells
resolves10.1007/s00125-003-1224-3
Globular adiponectin upregulates nitric oxide production in vascular endothelial cells
resolves10.1097/00004872-200309000-00015
Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertension
resolves10.1016/j.bbrc.2005.03.060
Hypergravity induces expression of cyclooxygenase-2 in the heart vessels
resolves10.1152/ajpheart.01130.2005
COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice
resolves10.1161/hc3301.092790
Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries
resolves10.1172/JCI29709
Adiponectin modulates inflammatory reactions via calreticulin receptor–dependent clearance of early apoptotic bodies
resolves10.1161/01.CIR.0000055188.83694.B3
Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue
resolves10.2337/diabetes.52.4.942
Association Between Adiponectin and Mediators of Inflammation in Obese Women
resolves10.2337/diacare.26.6.1745
Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian
resolves10.1001/jama.289.14.1799
Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women
resolves10.1182/blood.V96.5.1723
Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages
resolves10.1016/j.febslet.2005.11.019
Adiponectin inhibits Toll‐like receptor family‐induced signaling
resolves10.1161/CIRCRESAHA.109.194506
Adiponectin Suppresses Pathological Microvessel Formation in Retina Through Modulation of Tumor Necrosis Factor-α Expression
resolves10.1161/01.CIR.103.8.1057
Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages
resolves10.1161/CIRCRESAHA.107.164988
Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis
resolves10.1172/JCI200319451
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
resolves10.1172/JCI29881
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
resolves10.1161/ATVBAHA.107.147124
Angiotensin II Receptor Blocker Inhibits Neointimal Hyperplasia Through Regulation of Smooth Muscle–Like Progenitor Cells
resolves10.1016/j.clinthera.2006.10.012
The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension
resolves10.1016/j.metabol.2008.04.024
Effects of losartan on serum total and high–molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome
resolves10.1536/ihj.50.501
Effects of ARB or ACE-Inhibitor Administration on Plasma Levels of Aldosterone and Adiponectin in Hypertension
resolves10.1007/BF03349207
The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients
resolves10.1016/j.metabol.2005.10.009
Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance
resolves10.1038/sj.ki.5001810
Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation
resolves10.1161/01.HYP.0000123072.34629.57
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity
resolves10.2337/diabetes.50.9.2094
PPARγ Ligands Increase Expression and Plasma Concentrations of Adiponectin, an Adipose-Derived Protein
resolves10.2337/diabetes.52.7.1655
Induction of Adiponectin, a Fat-Derived Antidiabetic and Antiatherogenic Factor, by Nuclear Receptors
resolves10.1152/ajpendo.00187.2006
Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes
resolves10.1152/ajpendo.90359.2008
Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue
resolves10.1210/en.2009-1501
Peroxisome Proliferator-Activated Receptor-γ Increases Adiponectin Secretion via Transcriptional Repression of Endoplasmic Reticulum Chaperone Protein ERp44
resolves10.1161/01.CIR.0000127955.36250.65
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
resolves10.1016/S0140-6736(02)08089-3
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
resolves10.1016/S0140-6736(04)16451-9
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
resolves10.1097/01.hjh.0000234122.55895.5b
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial
resolves10.1536/ihj.50.73
Telmisartan Decreases Plasma Levels of Asymmetrical Dimethyl-L-Arginine and Improves Lipid and Glucose Metabolism and Vascular Function
The 1 reference without a DOI — listed, not checked
no DOI — not checked17_33897174
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1038/ajh.2010.216"><img src="https://citestamp.com/citestamped/10.1038/ajh.2010.216/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1038/ajh.2010.216)